But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...
A new jab, which will help prevent HIV transmissions, has been described as a ‘game changer’ by an LGBT charity in Northern ...
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
Tatenda Makoni is a Zimbabwean-born medical student at the Medical College of Wisconsin whose work bridges global health and ...
Lenacapavir is an injectable medicine that only needs to be taken twice a year, making it easier to use than daily HIV pills.
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
The city's axess sexual health service is piloting a new online platform that will deliver preventative HIV medication PrEP direct to patients without the need for them to have an in-person ...